Medicenna Therapeutics Corp.

09:55 AM EST - Medicenna Therapeutics Corp. : Reported a net loss of $2,181,022 or $0.09 per share for the three months ended December 31, 2017, compared to a loss of $2,178,966 or $0.13 per share for the three months ended December 31, 2016. Medicenna Therapeutics Corp. shares T.MDNA are trading up $0.02 at $1.95.